FIGHT Research

Philadelphia FIGHT (FIGHT) was founded as the Community-Based Research Initiative on AIDS as a partnership of individuals living with HIV/AIDS and clinicians who joined together to improve the lives of people living with the disease by testing potential treatments for HIV/AIDS and its complications. Today, clinicians at FIGHT continue to be involved in a number of studies.

What is a clinical trial?

A clinical trial is a controlled experiment in which people take medication for a specified time to determine its effectiveness and safety. Information gathered from clinical trials help create future treatments. Clinical trials are currently the most effective way to help people who have exhausted all proven therapies and to develop new and better treatments for people living with HIV/AIDS.

Who can enroll in a trial?

Each clinical trial has specific requirements; anyone meeting those requirements may be eligible to enroll in a trial. FIGHT clinical trials are free and participation is voluntary. Before participating in a study, patients go through a consenting process, which explains all the risks and benefits of that particular study. Participants may withdraw from clinical trials at any time without affecting access to their health care.

Click the link to view ongoing trials conducted at Philadelphia FIGHT Community Health Centers.

If you are interested in participating in clinical trials, please contact the research staff of Philadelphia FIGHT at 215-525-8695.

What’s new in FIGHT Research?

FIGHT is pleased to introduce 2 new Research Assistants, Morgan Culver, MS and Meghan Swyryn, BA. Both Morgan and Meghan have joined the team full-time and will be an integral part of the exciting research going on at FIGHT. Morgan earned her Master’s Degree at the London School of Hygiene and Tropical Medicine and was and employee of the NO/AIDS Taskforce helping those diagnosed with Hepatitis C and HIV link to care. Meghan Swyryn is a recent graduate of the University of Pennsylvania where she worked with Dr. Kendra Viner in Hepatitis B and C prevention. Please extend a warm welcome to both Morgan and Meghan!

Emily Kobayashi and Nilima Patel who presented original research at the University of the Sciences Research Day on April 6, 2017

Congratulations to Emily Kobayashi and Nilima Patel who presented original research at the University of the Sciences Research Day on April 6th. Both Emily and Nilima designed and completed research projects while rotating at the Lax Center under the supervision of Angela Kapalko, PA-C. Emily sought to evaluate the state of HIV resistance between for both treatment-naïve and treatment-experienced patients while Nilima sought to compare Pre and Post bone mineral density testing results in aging HIV positive patients. Both projects represent the dedication and hard work displayed by these PA students to the fields of HIV and public health.

Emily Kobayashi and Nilima Patel who presented original research at the University of the Sciences Research Day on April 6, 2017

Program Information

  • Location: 1233 Locust St, 5th floor, Philadelphia PA 19107
  • Phone: 215-525-8695

Spotlight On

Karam Mounzer, MD

Dr. Mounzer identified two major gaps in the care of patients with HIV/hepatitis C (HCV) co-infection, and the complexity of multidrug-resistant HIV treatment. He is involved with many clinical trials focusing on drug development and better understanding of HIV immunopathogenesis with the Wistar Institute. He is involved in teaching and mentoring fellows, residents and students.

Learn More

June is AIDS Education Month

AIDS Education Month June
June 2017 is the 23rd year that Philadelphia FIGHT hosted AIDS Education Month (AEM), a series of events throughout Philadelphia to increase AIDS awareness and to bring people together to find strategies to combat the virus. Over 10,000 individuals are directly reached by AEM every June. Learn About AIDS Education Month